George Simeon
Director
Sale 10b5-1
- Shares
- 14,514
- Price
- $49.63
- Value
- $720,373
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•57 filings
CRSP
CRISPR Therapeutics AG
Net sales of $2.2M over the last 3 months
3 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$2,247,250
0 buyers · 3 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$11,864,697
5 distinct insiders
Highlighted alerts
3
13 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get CRSP insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
CRSP overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
100
Raw transactions
Everything returned by the filing
16
Voluntary view
P/S trades after deterministic checks
90
Administrative noise
Stored, never alerted
17
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- S
- Shares
- 47,837
- Price
- $49.78
- Footnotes
- 3
Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. This restricted stock unit award was granted on October 16, 2024 with respect to 400,000 Common Shares, with (i) one quarter of the shares vesting on October 16, 2025, (ii) one quarter of the shares vesting on October 16, 2026, (iii) one quarter of the shares vesting on October 16, 2027, and (iv) one quarter of the shares vesting on October 16, 2028.
Raspberry interpretation
Informational — no alert
Reason: tax_withholding. The filing footnotes identify tax withholding.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
KASINGER JAMES R.
General Counsel and Secretary
Sale 10b5-1
- Shares
- 1,990
- Price
- $60.04
- Value
- $119,481
KASINGER JAMES R.
General Counsel and Secretary
Sale 10b5-1
- Shares
- 10,400
- Price
- $60.24
- Value
- $626,460
Behbahani Ali
Director
SaleAlert
- Shares
- 13,679
- Price
- $57.09
- Value
- $780,935
Prasad Raju
Chief Financial Officer
Sale 10b5-1
- Shares
- 34,972
- Price
- $60.19
- Value
- $2,104,965
Kulkarni Samarth
Chief Executive Officer
Sale 10b5-1
- Shares
- 60,000
- Price
- $60.23
- Value
- $3,613,800
Kulkarni Samarth
Chief Executive Officer
Sale 10b5-1
- Shares
- 8,567
- Price
- $52.10
- Value
- $446,341
Kulkarni Samarth
Chief Executive Officer
Sale 10b5-1
- Shares
- 21,433
- Price
- $51.61
- Value
- $1,106,157
Prasad Raju
Chief Financial Officer
Sale 10b5-1
- Shares
- 5,763
- Price
- $60.21
- Value
- $347,010
Prasad Raju
Chief Financial Officer
Sale 10b5-1
- Shares
- 5,004
- Price
- $60.00
- Value
- $300,240
Prasad Raju
Chief Financial Officer
Sale 10b5-1
- Shares
- 18,933
- Price
- $60.18
- Value
- $1,139,386
Prasad Raju
Chief Financial Officer
Sale 10b5-1
- Shares
- 1,000
- Price
- $56.89
- Value
- $56,886
Prasad Raju
Chief Financial Officer
Sale 10b5-1
- Shares
- 5,472
- Price
- $56.33
- Value
- $308,262
Prasad Raju
Chief Financial Officer
Sale 10b5-1
- Shares
- 3,528
- Price
- $55.10
- Value
- $194,401
Treco Douglas A
Director
PurchaseAlert
- Shares
- 20,000
- Price
- $57.03
- Value
- $1,140,600
Patel Naimish
Chief Medical Officer
PurchaseAlert
- Shares
- 1,508
- Price
- $32.96
- Value
- $49,704
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Oct 14, 2026 | George Simeon Director | Sale | 14,514 | $49.63 | $720,373 | |
| Oct 06, 2026 | KASINGER JAMES R. General Counsel and Secretary | Sale | 1,990 | $60.04 | $119,481 | |
| Sep 22, 2026 | KASINGER JAMES R. General Counsel and Secretary | Sale | 10,400 | $60.24 | $626,460 | |
| Sep 17, 2026 | Behbahani Ali Director | Sale | 13,679 | $57.09 | $780,935 | |
| Jan 22, 2026 | Prasad Raju Chief Financial Officer | Sale | 34,972 | $60.19 | $2,104,965 | |
| Jan 22, 2026 | Kulkarni Samarth Chief Executive Officer | Sale | 60,000 | $60.23 | $3,613,800 | |
| Jan 20, 2026 | Kulkarni Samarth Chief Executive Officer | Sale | 8,567 | $52.10 | $446,341 | |
| Jan 20, 2026 | Kulkarni Samarth Chief Executive Officer | Sale | 21,433 | $51.61 | $1,106,157 | |
| Jan 06, 2026 | Prasad Raju Chief Financial Officer | Sale | 5,763 | $60.21 | $347,010 | |
| Jan 06, 2026 | Prasad Raju Chief Financial Officer | Sale | 5,004 | $60.00 | $300,240 | |
| Jan 06, 2026 | Prasad Raju Chief Financial Officer | Sale | 18,933 | $60.18 | $1,139,386 | |
| Dec 22, 2025 | Prasad Raju Chief Financial Officer | Sale | 1,000 | $56.89 | $56,886 | |
| Dec 22, 2025 | Prasad Raju Chief Financial Officer | Sale | 5,472 | $56.33 | $308,262 | |
| Dec 22, 2025 | Prasad Raju Chief Financial Officer | Sale | 3,528 | $55.10 | $194,401 | |
| Aug 06, 2025 | Treco Douglas A Director | Purchase | 20,000 | $57.03 | $1,140,600 | |
| Apr 03, 2025 | Patel Naimish Chief Medical Officer | Purchase | 1,508 | $32.96 | $49,704 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.